Publication | Closed Access

Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial

Renin-angiotensin System InhibitorsHypertensionRenal FunctionRenal DiseaseMedicineDiabetesPharmacologyType 2Diabetic Kidney DiseasePlacebo-controlled TrialChronic Kidney DiseaseNephrology